Cronos Group Inc. Common Share CRON
i
Market dataready · fetched 2026-11-13T19:12:01.235Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-01-15
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T19:11:17.535374506Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-13T19:12:00.265199+00:00
Cronos Group Inc. Common Share options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 4.15 | 47.3% | 24.0% | 2.58 | 101.3% | 29.7% |
| 25Δ | 3.96 | 44.2% | 18.8% | 2.73 | 92.3% | 25.8% |
| 30Δ | 3.86 | 44.5% | 16.9% | 2.88 | 83.2% | 21.9% |
| 35Δ | 3.77 | 44.7% | 14.9% | 3.03 | 74.2% | 18.0% |
| 40Δ | 3.68 | 45.0% | 13.0% | 3.18 | 65.1% | 14.1% |
| 45Δ | 3.58 | 45.2% | 11.1% | 3.34 | 56.1% | 10.3% |
| 50Δ | 3.49 | 45.4% | 9.3% | 3.49 | 47.0% | 6.4% |
| 55Δ | 3.41 | 45.0% | 8.2% | |||
| 60Δ | 3.33 | 44.6% | 7.1% | |||
| 65Δ | 3.24 | 44.1% | 6.0% | |||
| 70Δ | 3.16 | 43.7% | 4.9% | |||
| 75Δ | 3.08 | 43.3% | 3.9% | |||
| 80Δ | 3.00 | 43.0% | 2.8% | |||
20Δ
- Pseudo strike
- 4.15
- IV
- 47.3%
- B/E move
- 24.0%
- Pseudo strike
- 2.58
- IV
- 101.3%
- B/E move
- 29.7%
25Δ
- Pseudo strike
- 3.96
- IV
- 44.2%
- B/E move
- 18.8%
- Pseudo strike
- 2.73
- IV
- 92.3%
- B/E move
- 25.8%
30Δ
- Pseudo strike
- 3.86
- IV
- 44.5%
- B/E move
- 16.9%
- Pseudo strike
- 2.88
- IV
- 83.2%
- B/E move
- 21.9%
35Δ
- Pseudo strike
- 3.77
- IV
- 44.7%
- B/E move
- 14.9%
- Pseudo strike
- 3.03
- IV
- 74.2%
- B/E move
- 18.0%
40Δ
- Pseudo strike
- 3.68
- IV
- 45.0%
- B/E move
- 13.0%
- Pseudo strike
- 3.18
- IV
- 65.1%
- B/E move
- 14.1%
45Δ
- Pseudo strike
- 3.58
- IV
- 45.2%
- B/E move
- 11.1%
- Pseudo strike
- 3.34
- IV
- 56.1%
- B/E move
- 10.3%
50Δ
- Pseudo strike
- 3.49
- IV
- 45.4%
- B/E move
- 9.3%
- Pseudo strike
- 3.49
- IV
- 47.0%
- B/E move
- 6.4%
55Δ
- Pseudo strike
- 3.41
- IV
- 45.0%
- B/E move
- 8.2%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 3.33
- IV
- 44.6%
- B/E move
- 7.1%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 3.24
- IV
- 44.1%
- B/E move
- 6.0%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 3.16
- IV
- 43.7%
- B/E move
- 4.9%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 3.08
- IV
- 43.3%
- B/E move
- 3.9%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 3.00
- IV
- 43.0%
- B/E move
- 2.8%
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Drug Manufacturers - Specialty & Generic
DERM
Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
More →EBS
Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations that address…
More →ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals. The company is headquartered in…
More →EOLS
Description unavailable
More →ETON
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and marketing pharmaceuticals for rare diseases. The company is headquartered in Deer Park,…
More →GLAS
Description unavailable
More →